AUBN
Auburn National Bancorporation, Inc.
There isn't enough reported data to score AUBN yet.
MS
Morgan Stanley
MS's fundamentals are strong: revenue grew 16% and earnings per share grew 29%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.
AUBN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
AUBN's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like AUBN.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
AUBN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 10x | $25.91 | -0.1% |
| Current | 10x | $25.93 | — |
| Fair | 14x | $34.22 | +32% |
| Expensive | 21x | $53.36 | +106% |
Historical ranges are pointers, not guarantees.
AUBN has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
AUBN Forward outlook
There aren't enough analyst estimates for AUBN to show an outlook.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
AUBN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.49 | +21% |
| Q2 2026 | $2.41 | +26% |
| Q1 2026 | $2.27 | +20% |
| Q4 2025 | $2.08 | +13% |
| Q3 2025 | $2.05 | +720% |
| Q2 2025 | $1.91 | +961% |
| Q1 2025 | $1.89 | +722% |
| Q4 2024 | $1.84 | +360% |
AUBN has the edge over MS on earnings, with stronger typical year-over-year growth.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS's earnings per share have climbed steadily: $12.60 over the past year, up 29% from the year before, and higher year over year for 10 quarters in a row.
AUBN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $9M | +7% |
| Q2 2026 | $8.8M | +7.8% |
| Q1 2026 | $8.6M | +11% |
| Q4 2025 | $8.5M | +8.4% |
| Q3 2025 | $8.4M | +10% |
| Q2 2025 | $8.1M | +6.9% |
| Q1 2025 | $7.8M | +3.3% |
| Q4 2024 | $7.8M | +1140% |
AUBN's revenue has grown year over year for nine quarters in a row: $9M last quarter, up 7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 35% | +1.1 points |
| Q2 2026 | 33% | +4.7 points |
| Q1 2026 | 32% | +7.8 points |
| Q4 2025 | 25% | -5.5 points |
| Q3 2025 | 34% | +4.3 points |
| Q2 2025 | 29% | -0.6 points |
| Q1 2025 | 25% | +4.3 points |
| Q4 2024 | 31% | +904 points |
AUBN has the edge over MS on profitability, with a higher operating margin.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over AUBN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
AUBN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $1.5M | -29% |
| Q1 2026 | $2.5M | -3.5% |
| Q3 2025 | $4.1M | +117% |
| Q2 2025 | $2.1M | -30% |
| Q1 2025 | $2.6M | -15% |
| Q3 2024 | $1.9M | -43% |
| Q2 2024 | $3M | +23% |
| Q1 2024 | $3.1M | -37% |
AUBN has the stronger cash trend. Its trailing FCF is down 9.6% versus its history, compared with MS at down 492%.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
AUBN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -6.9K shares |
| 1 year | -0.3% | -10.8K shares |
| 3 years | -0.3% | -11.2K shares |
| 5 years | -1.2% | -42.4K shares |
| Available history | -3% | -108K shares |
AUBN has 3M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $195,000 |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | $130,000 |
| Q2 2023 | $35,000 |
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over AUBN on shareholder dilution, with a more favorable share count trend.
AUBN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.3x | Net Cash |
| Q2 2026 | -1.6x | Net Cash |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -2.0x | Net Cash |
| Q3 2025 | -1.3x | Net Cash |
| Q2 2025 | -1.7x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -1.5x | Net Cash |
AUBN has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
AUBN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.5 | Neutral |
| Stochastic | 53.4 | Neutral |
AUBN's weekly RSI is 49 (neutral) and its Stochastic is 53 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
AUBN PE vs Financial Services Sector
| Metric | AUBN | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 13x | 20% below |
| PE % | 17 | 63 | 46 pts below |
AUBN has the edge over MS on valuation relative to its sector.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
AUBN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $26.4 | 1.9% below |
| 20 week MA | $26.6 | 2.5% below |
| 50 week MA | $25.5 | 1.6% above |
| 100 week MA | $24.5 | 5.9% above |
| 200 week MA | $22.7 | 14% above |
AUBN has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 14% above its 200-week average.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
AUBN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $53.8 | $42.6 | -21% |
| 2021 | $42.6 | $32.1 | -24% |
| 2022 | $32.1 | $23.3 | -27% |
| 2023 | $23.3 | $21.3 | -8.7% |
| 2024 | $21.3 | $23.9 | +12% |
| 2025 | $23.9 | $27.0 | +13% |
| 2026 YTD | $27.0 | $25.9 | -3.8% |
AUBN has finished lower in four of the last six years. It's down 3.8% so far in 2026.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over AUBN on returns for 2026, with the stronger performance.